FDA denies marketing of over 250 e-cigarette flavors.

May.19.2023
FDA denies marketing of over 250 e-cigarette flavors.
FDA rejects marketing of over 250 flavored and tobacco-flavored e-liquids from Mothers Milk WTA company.

On May 18th, the United States Food and Drug Administration (FDA) issued a marketing denial order to the Mothers Milk WTA company for over 250 flavored and tobacco-flavored electronic cigarette oils. After an initial review, the FDA found that the company's application lacked evidence to demonstrate that their products could protect public health, and thus refused to approve them for sale.


According to Dr. Matthew Farrelly, the Director of the Scientific Office at the FDA's Center for Tobacco Products (CTP), strict scientific pre-market review is a crucial responsibility for ensuring the safety of new tobacco products. The FDA will continue to evaluate these applications based on public health standards, taking into account the risks and benefits of tobacco products for the public.


The pre-market tobacco product application (PMTA) review process is composed of multiple stages. If an application does not meet the requirements of a particular stage, the FDA may reject the application or ask for it to be resubmitted. During the final substantive review stage, the FDA assesses the scientific information and data included in the application to determine whether the marketing of the new product meets the public health standards set by the 2009 Family Smoking Prevention and Tobacco Control Act.


After undergoing a rigorous scientific review by the FDA, tobacco products that have received a marketing denial order cannot be sold, distributed, or marketed in the United States. Additionally, these products cannot be commercially transported across state lines or introduced to the market, and if already on the market, they must be taken off. Manufacturers, distributors, and retailers who sell, distribute, or promote these products will be in violation of the law and may face enforcement action.


As of now, the Food and Drug Administration (FDA) has received over 26 million applications for tobacco products to be marketed, with a majority of them being for electronic cigarettes. The FDA has indicated that they have made decisions regarding 99% of these applications which include over one million for non-tobacco nicotine products as well as those containing synthetic nicotine.


The FDA has authorized the sale or distribution of 23 tobacco-flavored e-cigarette products and devices, which are currently the only legally sold e-cigarette products in the United States.


The FDA has recently released several regulatory documents related to electronic cigarettes. On May 15th, the FDA issued a marketing refusal order to 10 companies for 6,500 flavored electronic cigarettes and e-liquid products. On May 17th, the FDA issued an "Import Alert 98-06" to multiple Chinese e-cigarette companies, stating that they will detain new tobacco products that have not been tested without market approval. This alert involves importers, manufacturers, and transporters of e-cigarette brands such as ELFBAR, EBDESIGN, and Esco Bar from China, South Korea, and the United States.


References:


The FDA has rejected the marketing of more than 250 e-liquids that are flavored or flavored with tobacco.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

ITGA 与 2Firsts 签署战略合作备忘录,共同支持全球烟草种植者
ITGA 与 2Firsts 签署战略合作备忘录,共同支持全球烟草种植者
ITGA Annual General Meeting 2025 held in Germany alongside InterTabac/InterSupply 2025 showcases global tobacco supply chain opportunities.
Sep.23 by 2FIRSTS.ai
HSSP INTL signs agreement with COTY to expand e-cigarette business in Middle East and Australia
HSSP INTL signs agreement with COTY to expand e-cigarette business in Middle East and Australia
HSSP INTL(03626.HK) partners with COTY to establish e-cigarette venture in UAE, expand distribution of Heaven Gifts brand.
Oct.30 by 2FIRSTS.ai
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
ITGA Unites Global Tobacco Growers at InterTabac / InterSupply 2025
ITGA Unites Global Tobacco Growers at InterTabac / InterSupply 2025
At InterTabac/InterSupply 2025 in Dortmund, ITGA gathered growers from four continents to address market trends, regulation, and sustainability. The AGM reaffirmed ITGA’s mission to secure farmers a living income and highlighted the need for grower-led advocacy to ensure fairness, transparency, and resilience in the global tobacco sector.
Sep.23
Three Refuse Truck Fires in Two Weeks in Glasgow; GMB Calls for Stronger E-Cigarette Battery Recycling and Public Awareness
Three Refuse Truck Fires in Two Weeks in Glasgow; GMB Calls for Stronger E-Cigarette Battery Recycling and Public Awareness
The GMB union says three compartment fires occurred in Glasgow’s newly deployed refuse trucks over the past two weeks, with initial checks pointing to lithium-ion batteries from e-cigarettes being crushed and igniting during compaction.
Sep.23 by 2FIRSTS.ai
Research Brief | Current Use of Cigarettes, E-Cigarettes, and Cannabis Is Significantly Associated with Xerostomia
Research Brief | Current Use of Cigarettes, E-Cigarettes, and Cannabis Is Significantly Associated with Xerostomia
About 9.7% of 29,721 U.S. adults (18+) surveyed in 2022–2023 reported their mouth felt dry “frequently” or “always.” After multivariable adjustment, past-30-day use of cigarettes (AOR ≈ 1.52), e-cigarettes (≈ 1.46), or cannabis (≈ 1.57) was each linked to higher odds of xerostomia. Daily use showed stronger associations (cigarettes ≈ 1.67; e-cigarettes ≈ 1.80; cannabis ≈ 2.15). Concurrent use of all three products had the highest odds (AOR ≈ 3.80). The authors suggest dental professionals factor
Sep.12 by 2FIRSTS.ai